Hypersensitivity Reaction Incidence Patterns and Risk Factors of Iodinated Contrast Media

Dong-Hwi Kim, J. Mun, Jun-Hwan Kim, Seungh-wan Yun, Hwan-Sang Park, Chang-Kon Kim, Yeong-Deok Kim
{"title":"Hypersensitivity Reaction Incidence Patterns and Risk Factors of Iodinated Contrast Media","authors":"Dong-Hwi Kim, J. Mun, Jun-Hwan Kim, Seungh-wan Yun, Hwan-Sang Park, Chang-Kon Kim, Yeong-Deok Kim","doi":"10.31320/jksct.2023.25.1.37","DOIUrl":null,"url":null,"abstract":"The subjects of this study were 2,798 patients who experienced hypersensitivity reaction of contrast media among 72,910 who had had iodinated contrast media administered intravenously and CT examination at our hospital. Retrospective survey was conducted with these subjects. Their age, gender, hypersensitivity reaction symptoms, prepare methods for the patients who had previous hypersensitivity reaction of contrast media, and contrast media administered were analyzed. When it came to the hypersensitivity reaction incidence of contrast media, women and patients aged less than 60 had the high risk of the reaction. Even if patients had previous contrast media hypersensitivity reaction, their hypersensitivity reaction incidence risk was reduced as they had an appropriate premedication drug administered and contrast media were changed. Regarding the hypersensitivity reaction incidence rate by contrast media, Iopromide’s hypersensitivity reaction incidence rate was significantly high, whereas Iohexol and Ioversol had low incidence rates. In order to prevent contrast media hypersensitivity reaction recurrence, it is preferentially necessary to change a contrast media to a different one without reuse of causative contrast media, rather than to use a premedication drug only. Along with that, it is necessary to administer a premedication drug.","PeriodicalId":272693,"journal":{"name":"Korean Society of Computed Tomographic Technology","volume":"10 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean Society of Computed Tomographic Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31320/jksct.2023.25.1.37","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The subjects of this study were 2,798 patients who experienced hypersensitivity reaction of contrast media among 72,910 who had had iodinated contrast media administered intravenously and CT examination at our hospital. Retrospective survey was conducted with these subjects. Their age, gender, hypersensitivity reaction symptoms, prepare methods for the patients who had previous hypersensitivity reaction of contrast media, and contrast media administered were analyzed. When it came to the hypersensitivity reaction incidence of contrast media, women and patients aged less than 60 had the high risk of the reaction. Even if patients had previous contrast media hypersensitivity reaction, their hypersensitivity reaction incidence risk was reduced as they had an appropriate premedication drug administered and contrast media were changed. Regarding the hypersensitivity reaction incidence rate by contrast media, Iopromide’s hypersensitivity reaction incidence rate was significantly high, whereas Iohexol and Ioversol had low incidence rates. In order to prevent contrast media hypersensitivity reaction recurrence, it is preferentially necessary to change a contrast media to a different one without reuse of causative contrast media, rather than to use a premedication drug only. Along with that, it is necessary to administer a premedication drug.
碘化造影剂超敏反应发生率及危险因素分析
本研究的对象是72910例在我院静脉注射碘化造影剂并进行CT检查的造影剂超敏反应患者中的2798例。对这些受试者进行回顾性调查。分析年龄、性别、超敏反应症状、既往造影剂超敏反应患者的制备方法、造影剂给药情况。造影剂超敏反应发生率方面,女性及60岁以下患者发生反应的风险较高。即使患者既往有造影剂超敏反应,但由于给药前给予适当的药物和改变造影剂,其超敏反应发生率降低。对比剂超敏反应发生率方面,碘丙胺的超敏反应发生率明显高,而碘己醇和艾弗索尔的超敏反应发生率较低。为了防止造影剂超敏反应的再次发生,在不重复使用造影剂的情况下,优先更换造影剂,而不是仅仅使用药物前的药物。与此同时,有必要在用药前服用药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信